Clinic
Ihc Health Services INC
Ihc Health Services INC was paid $4.31M by Medicaid between Jan 2018 and Nov 2023, across 50 billing codes. Its largest line is 8888888, Internal/system code - not a standard HCPCS code — 78% of everything it billed.
33Billing provider infoIHC HEALTH SERVICES INC
HEBER CITY, UT 84032
HEBER CITY, UT 84032
33aNPI1316055205assigned 08/29/2006
33bProvider typeEnd-Stage Renal Disease (ESRD) Treatment Clinic/Center
28Total paid$4.31M
24GClaims33,046
24DCodes billed50
24AFirst – last monthJan 2018 – Nov 2023
Compared with peers
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in Utah
Rank by total paid#2 of 43
Median peer was paid$240K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SMITH, DENIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,409 | $472K | |
| 2019 | 5,682 | $619K | |
| 2020 | 6,541 | $794K | |
| 2021 | 8,704 | $1.03M | |
| 2022 | 7,530 | $1.35M | |
| 2023 | 180 | $45K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 8888888 | Internal/system code - not a standard HCPCS code | 78% | 4,837 | 2,571 | $3.37M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.6% | 3,905 | 3,194 | $284K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.7% | 1,545 | 1,255 | $115K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.2% | 2,087 | 1,795 | $96K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.0% | 479 | 439 | $86K |
| 80050 | General health panel | 1.4% | 305 | 285 | $59K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.0% | 1,843 | 1,528 | $45K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 462 | 416 | $37K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,051 | 947 | $26K |
| 80053 | Comprehensive metabolic panel | <1% | 3,478 | 2,887 | $24K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 587 | 518 | $24K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,144 | 966 | $21K |
38 more codes
| 81001 | <1% | 1,538 | $19K | |
| 99285 | Emergency room visit (most serious) | <1% | 1,304 | $17K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 368 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 31 | $9K |
| 87081 | <1% | 461 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 463 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 165 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 48 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 577 | $4K |
| 71045 | Radiologic examination, chest; single view | <1% | 193 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,032 | $3K |
| 80061 | Lipid panel | <1% | 460 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 854 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 46 | $2K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 27 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 151 | $2K |
| 85027 | <1% | 14 | $2K | |
| 84484 | <1% | 541 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 70 | $1K |
| 96376 | <1% | 16 | $1K | |
| 87186 | <1% | 44 | $984.06 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13 | $957.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 203 | $776.21 |
| 84702 | <1% | 193 | $625.43 | |
| 83605 | <1% | 770 | $537.88 | |
| 83690 | <1% | 494 | $527.55 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 16 | $397.58 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 169 | $281.80 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 133 | $208.40 |
| 85610 | <1% | 28 | $48.58 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 488 | $42.21 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 40 | $5.02 |
| 86140 | 0% | 252 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 37 | $0.00 |
| 85379 | 0% | 39 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 14 | $0.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 17 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, DENIS (CFO)
| Provider | Location | Paid |
|---|---|---|
| Ihc Health Services, INC. | Murray, UT | $68.77M |
| Ihc Health Services, INC. | St George, UT | $65.78M |
| Ihc Health Services INC | Ogden, UT | $54.08M |
| Ihc Health Services, INC. | Provo, UT | $44.35M |
| Ihc Health Services INC | Logan, UT | $25.34M |
| Ihc Health Services, INC. | Cedar City, UT | $20.40M |
| Ihc Health Services, INC. | Salt Lake City, UT | $19.91M |
| Ihc Health Services, INC. | American Fork, UT | $17.19M |
| Ihc Health Services INC | Riverton, UT | $15.31M |
| Ihc Health Services INC | Sandy, UT | $11.66M |
| Ihc Health Services, INC. | Layton, UT | $11.61M |
| Ihc Health Services, INC. | Burley, ID | $5.14M |
| Ihc Health Services INC | Murray, UT | $4.64M |
| Ihc Health Services INC | St George, UT | $4.35M |
| Ihc Health Services, INC. | Orem, UT | $4.18M |
| Ihc Health Services, INC. | Richfield, UT | $3.87M |
| Ihc Health Services INC | Tremonton, UT | $3.55M |
| Ihc Health Services, INC. | Spanish Fork, UT | $3.49M |
| Ihc Health Services INC | Park City, UT | $2.53M |
| Ihc Health Services, INC. | Mt Pleasant, UT | $2.34M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.